Metronomic Chemotherapy Combined With Bevacizumab and Erlotinib in Patients With Metastatic HER2-Negative Breast Cancer: Clinical and Biological Activity

Authors:
  • GCGiuseppe Cancello
    Giuseppe Cancello
  • VBVincenzo Bagnardi
    Vincenzo Bagnardi
  • DPDavide Pastrello
    Davide Pastrello
  • SDSilvia Dellapasqua
    Silvia Dellapasqua
  • GPGino Perri
    Gino Perri
  • GVGiuseppe Viale
    Giuseppe Viale
  • ALAlberto Luini
    Alberto Luini
  • MIMattia Intra
    Mattia Intra
  • ACAngelica Calleri
    Angelica Calleri
  • CRCristiano Rampinelli
    Cristiano Rampinelli

Abstract
No abstract available

This publication has 20 references indexed in Scilit: